Sitagliptin vs Mitiglinide Switched From Insulin in T2DSitagliptin vs Mitiglinide Switched From Insulin in T2D

A new study examines the feasibility and efficacy of substituting these oral hypoglycemic agents for insulin therapy in patients with type 2 diabetes. BMJ Open Diabetes Research & Care

Source: Medscape Today Headlines - October 28, 2015 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news